Purity
≥ 98% (HPLC)
Wolverine
BPC-157 + TB-500
Supplies BPC-157 (5mg) and TB-500 (5mg) together. Both are characterised in the tissue-repair literature; the preparation is offered for research protocols examining the two in combination rather than separately.
Studied Mechanism
Pairs BPC-157's angiogenic and growth-factor modulation with TB-500's reported actin-binding and cell-migration effects in study models.
Research References
For Research Use Only — Not for Human Consumption
For laboratory research use only. Not for human consumption. Not a drug, food, or cosmetic. Not intended to diagnose, treat, cure, or prevent any disease. Products are sold exclusively to qualified researchers and institutions. By purchasing, you confirm you are using these materials for lawful, in-vitro research purposes and assume all responsibility for safe handling.
Related compounds
BPC-157 + TB-500 + GHK-Cu
Blends
GLOW
Studied Mechanism
Combines the angiogenic and fibroblast-migration pathways associated with BPC-157 and TB-500 with the collagen and elastin gene-expression effects attributed to GHK-Cu in study models.
Key References
KPV + BPC-157 + TB-500 + GHK-Cu
Blends
KLOW
Studied Mechanism
Adds KPV's reported modulation of inflammatory signalling to the tissue-repair and collagen pathways associated with the other three components in study models.
Key References
Body Protection Compound
Repair & Recovery
BPC-157
Studied Mechanism
Investigated for promoting angiogenesis via the VEGFR2–Akt–eNOS pathway and modulating nitric-oxide and growth-factor systems that drive fibroblast migration and tissue repair.